Designing the Next Generation of HIV Prevention Efficacy Trials: Synopsis of a 2018 Symposium
A one-day symposium was held in Seattle, Washington on November 5, 2018, including a broad array of stakeholders in the HIV prevention community. The topic of discussion was the challenge of designing future HIV prevention efficacy trials, given the multiplicity and speed of changes in the field in...
Gespeichert in:
| Veröffentlicht in: | Statistical communications in infectious diseases 2019-08, Vol.11 (1) |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 1 |
| container_start_page | |
| container_title | Statistical communications in infectious diseases |
| container_volume | 11 |
| creator | Janes, Holly Donnell, Deborah Nason, Martha |
| description | A one-day symposium was held in Seattle, Washington on November 5, 2018, including a broad array of stakeholders in the HIV prevention community. The topic of discussion was the challenge of designing future HIV prevention efficacy trials, given the multiplicity and speed of changes in the field in recent years, the development and rollout of effective prevention tools, and the resultant complexity in designing trials to evaluate new HIV prevention products. The goal was to identify potential statistical trial design approaches worthy of further investigation, as well as gaps in understanding and logical next steps. We overview the themes that emerged from the presentations, panels, and floor discussions, and outline initial next steps in further exploring design options. |
| doi_str_mv | 10.1515/scid-2019-0004 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2271310121</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2271310121</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1621-9f452bfa91f23738a6d3da110e5d4e37cdf3945a5787fd10f9e40efaa02c5ec83</originalsourceid><addsrcrecordid>eNptUE1LAzEQDaJgrV49BzxvzST76U1qbQtFBas3CTE7qSntbk121f33Zq3gxdPMPN4H8wg5BzaCBJJLr20ZcQZFxBiLD8gAijiP4rRgh2TAwxGlAtgxOfF-zVia5YkYkJcb9HZV2WpFmzekd_jV0ClW6FRj64rWhs7mz_TB4QdWP8jEGKuV7ujSWbXxV_Sxq-qdt77nKhry8wBtd7W37faUHJlAwrPfOSRPt5PleBYt7qfz8fUi0pByiAoTJ_zVqAIMF5nIVVqKUgEwTMoYRaZLI4o4UUmWZ6YEZgqMGRqlGNcJ6lwMycXed-fq9xZ9I9d166oQKTnPILwNHAJrtGdpV3vv0Mids1vlOglM9hXKvkLZVyj7CoOg2As-1aZBV-LKtV1Y_tz_FwKA-AY3EnbX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2271310121</pqid></control><display><type>article</type><title>Designing the Next Generation of HIV Prevention Efficacy Trials: Synopsis of a 2018 Symposium</title><source>De Gruyter journals</source><creator>Janes, Holly ; Donnell, Deborah ; Nason, Martha</creator><creatorcontrib>Janes, Holly ; Donnell, Deborah ; Nason, Martha</creatorcontrib><description>A one-day symposium was held in Seattle, Washington on November 5, 2018, including a broad array of stakeholders in the HIV prevention community. The topic of discussion was the challenge of designing future HIV prevention efficacy trials, given the multiplicity and speed of changes in the field in recent years, the development and rollout of effective prevention tools, and the resultant complexity in designing trials to evaluate new HIV prevention products. The goal was to identify potential statistical trial design approaches worthy of further investigation, as well as gaps in understanding and logical next steps. We overview the themes that emerged from the presentations, panels, and floor discussions, and outline initial next steps in further exploring design options.</description><identifier>ISSN: 2194-6310</identifier><identifier>EISSN: 1948-4690</identifier><identifier>DOI: 10.1515/scid-2019-0004</identifier><language>eng</language><publisher>Berlin: De Gruyter</publisher><subject>clinical trial design ; Disease prevention ; efficacy trial design ; HIV ; HIV prevention ; Human immunodeficiency virus ; Prevention programs</subject><ispartof>Statistical communications in infectious diseases, 2019-08, Vol.11 (1)</ispartof><rights>2019 Walter de Gruyter GmbH, Berlin/Boston</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1621-9f452bfa91f23738a6d3da110e5d4e37cdf3945a5787fd10f9e40efaa02c5ec83</citedby><cites>FETCH-LOGICAL-c1621-9f452bfa91f23738a6d3da110e5d4e37cdf3945a5787fd10f9e40efaa02c5ec83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.degruyter.com/document/doi/10.1515/scid-2019-0004/pdf$$EPDF$$P50$$Gwalterdegruyter$$H</linktopdf><linktohtml>$$Uhttps://www.degruyter.com/document/doi/10.1515/scid-2019-0004/html$$EHTML$$P50$$Gwalterdegruyter$$H</linktohtml><link.rule.ids>315,781,785,27929,27930,66759,68543</link.rule.ids></links><search><creatorcontrib>Janes, Holly</creatorcontrib><creatorcontrib>Donnell, Deborah</creatorcontrib><creatorcontrib>Nason, Martha</creatorcontrib><title>Designing the Next Generation of HIV Prevention Efficacy Trials: Synopsis of a 2018 Symposium</title><title>Statistical communications in infectious diseases</title><description>A one-day symposium was held in Seattle, Washington on November 5, 2018, including a broad array of stakeholders in the HIV prevention community. The topic of discussion was the challenge of designing future HIV prevention efficacy trials, given the multiplicity and speed of changes in the field in recent years, the development and rollout of effective prevention tools, and the resultant complexity in designing trials to evaluate new HIV prevention products. The goal was to identify potential statistical trial design approaches worthy of further investigation, as well as gaps in understanding and logical next steps. We overview the themes that emerged from the presentations, panels, and floor discussions, and outline initial next steps in further exploring design options.</description><subject>clinical trial design</subject><subject>Disease prevention</subject><subject>efficacy trial design</subject><subject>HIV</subject><subject>HIV prevention</subject><subject>Human immunodeficiency virus</subject><subject>Prevention programs</subject><issn>2194-6310</issn><issn>1948-4690</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNptUE1LAzEQDaJgrV49BzxvzST76U1qbQtFBas3CTE7qSntbk121f33Zq3gxdPMPN4H8wg5BzaCBJJLr20ZcQZFxBiLD8gAijiP4rRgh2TAwxGlAtgxOfF-zVia5YkYkJcb9HZV2WpFmzekd_jV0ClW6FRj64rWhs7mz_TB4QdWP8jEGKuV7ujSWbXxV_Sxq-qdt77nKhry8wBtd7W37faUHJlAwrPfOSRPt5PleBYt7qfz8fUi0pByiAoTJ_zVqAIMF5nIVVqKUgEwTMoYRaZLI4o4UUmWZ6YEZgqMGRqlGNcJ6lwMycXed-fq9xZ9I9d166oQKTnPILwNHAJrtGdpV3vv0Mids1vlOglM9hXKvkLZVyj7CoOg2As-1aZBV-LKtV1Y_tz_FwKA-AY3EnbX</recordid><startdate>20190827</startdate><enddate>20190827</enddate><creator>Janes, Holly</creator><creator>Donnell, Deborah</creator><creator>Nason, Martha</creator><general>De Gruyter</general><general>Walter de Gruyter GmbH</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20190827</creationdate><title>Designing the Next Generation of HIV Prevention Efficacy Trials: Synopsis of a 2018 Symposium</title><author>Janes, Holly ; Donnell, Deborah ; Nason, Martha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1621-9f452bfa91f23738a6d3da110e5d4e37cdf3945a5787fd10f9e40efaa02c5ec83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>clinical trial design</topic><topic>Disease prevention</topic><topic>efficacy trial design</topic><topic>HIV</topic><topic>HIV prevention</topic><topic>Human immunodeficiency virus</topic><topic>Prevention programs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Janes, Holly</creatorcontrib><creatorcontrib>Donnell, Deborah</creatorcontrib><creatorcontrib>Nason, Martha</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Statistical communications in infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Janes, Holly</au><au>Donnell, Deborah</au><au>Nason, Martha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Designing the Next Generation of HIV Prevention Efficacy Trials: Synopsis of a 2018 Symposium</atitle><jtitle>Statistical communications in infectious diseases</jtitle><date>2019-08-27</date><risdate>2019</risdate><volume>11</volume><issue>1</issue><issn>2194-6310</issn><eissn>1948-4690</eissn><abstract>A one-day symposium was held in Seattle, Washington on November 5, 2018, including a broad array of stakeholders in the HIV prevention community. The topic of discussion was the challenge of designing future HIV prevention efficacy trials, given the multiplicity and speed of changes in the field in recent years, the development and rollout of effective prevention tools, and the resultant complexity in designing trials to evaluate new HIV prevention products. The goal was to identify potential statistical trial design approaches worthy of further investigation, as well as gaps in understanding and logical next steps. We overview the themes that emerged from the presentations, panels, and floor discussions, and outline initial next steps in further exploring design options.</abstract><cop>Berlin</cop><pub>De Gruyter</pub><doi>10.1515/scid-2019-0004</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2194-6310 |
| ispartof | Statistical communications in infectious diseases, 2019-08, Vol.11 (1) |
| issn | 2194-6310 1948-4690 |
| language | eng |
| recordid | cdi_proquest_journals_2271310121 |
| source | De Gruyter journals |
| subjects | clinical trial design Disease prevention efficacy trial design HIV HIV prevention Human immunodeficiency virus Prevention programs |
| title | Designing the Next Generation of HIV Prevention Efficacy Trials: Synopsis of a 2018 Symposium |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T22%3A40%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Designing%20the%20Next%20Generation%20of%20HIV%20Prevention%20Efficacy%20Trials:%20Synopsis%20of%20a%202018%20Symposium&rft.jtitle=Statistical%20communications%20in%20infectious%20diseases&rft.au=Janes,%20Holly&rft.date=2019-08-27&rft.volume=11&rft.issue=1&rft.issn=2194-6310&rft.eissn=1948-4690&rft_id=info:doi/10.1515/scid-2019-0004&rft_dat=%3Cproquest_cross%3E2271310121%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2271310121&rft_id=info:pmid/&rfr_iscdi=true |